Literature DB >> 2630360

Long term effectiveness of photocoagulation for diabetic maculopathy.

E G Davies1, R G Petty, E M Kohner.   

Abstract

The long term visual results of photocoagulation for diabetic maculopathy were determined in 128 eyes of 95 patients followed over ten years. The mean age of patients was 55.5 years and mean follow up time was 7 years. Ten year data were available on forty patients (62 eyes) and of the remainder the majority had died. Of those eyes initially with good vision (defined as 6/12 or better), 60% maintained this level of acuity at ten years and of those which deteriorated 50% became blind (defined as 6/60 or worse). A significantly greater proportion of eyes with exudative maculopathy (48%) had good final vision compared to eyes with oedematous and ischaemic maculopathy (26%).

Entities:  

Mesh:

Year:  1989        PMID: 2630360     DOI: 10.1038/eye.1989.119

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

Review 1.  Extracts from "concise clinical evidence". Diabetic retinopathy.

Authors:  Simon Harding
Journal:  BMJ       Date:  2003-05-10

Review 2.  Update on Screening for Sight-Threatening Diabetic Retinopathy.

Authors:  Peter H Scanlon
Journal:  Ophthalmic Res       Date:  2019-05-27       Impact factor: 2.892

3.  Diabetic retinopathy: preventing blindness in the 1990's.

Authors:  E M Kohner; M Porta
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

Review 4.  Diabetic retinopathy.

Authors:  E M Kohner
Journal:  BMJ       Date:  1993-11-06

5.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

6.  Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema.

Authors:  C Hudson; J G Flanagan; G S Turner; H C Chen; L B Young; D McLeod
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

7.  Clinically significant macular edema and survival in type 1 and type 2 diabetes.

Authors:  Flavio E Hirai; Michael D Knudtson; Barbara E K Klein; Ronald Klein
Journal:  Am J Ophthalmol       Date:  2008-01-28       Impact factor: 5.258

Review 8.  Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?

Authors:  Xiaodie Mu; Min Yang; Peiyao Ling; Aihua Wu; Hua Zhou; Jingting Jiang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-29       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.